Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

KRICT Achieves 100 kg Daily Production of Sustainable Aviation Fuel from Landfill Gas

February 4, 2026
Continue Reading
krict-achieves-100-kg-daily-production-of-sustainable-aviation-fuel-from-landfill-gas
Posted inBiotechnology

Stacking the Genetic Deck: How Certain Plant Hybrids Defy the Odds

February 4, 2026
Continue Reading
stacking-the-genetic-deck:-how-certain-plant-hybrids-defy-the-odds
Posted inBiotechnology

High Intake of Ultraprocessed Foods Potentially Increases Mortality Risk Among Cancer Survivors

February 4, 2026
Continue Reading
high-intake-of-ultraprocessed-foods-potentially-increases-mortality-risk-among-cancer-survivors
Posted inBiotechnology

Eco-Economic Gains of UHPFRC in Swiss Bridges

February 4, 2026
Continue Reading
eco-economic-gains-of-uhpfrc-in-swiss-bridges
Posted inBiotechnology

Renal Doppler’s Impact on Pediatric Nephrotic Syndrome

February 4, 2026
Continue Reading
renal-doppler’s-impact-on-pediatric-nephrotic-syndrome
Posted inBiotechnology

Tackling Bias and Oversight in Clinical AI

February 4, 2026
Continue Reading
tackling-bias-and-oversight-in-clinical-ai
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

editor’s-corner:-fierce-medtech’s-top-10-stories-of-2024-chart-the-industry’s-highs-and-lows
Posted inMedical Technology

Editor’s corner: Fierce Medtech’s top 10 stories of 2024 chart the industry’s highs and lows

December 23, 2024
A look back at our top stories of 2024 sees them fall into two major themes: promise, and a realignment…
Read More
fda-approves-humacyte’s-off-the-shelf-artery-implant-for-vascular-trauma-repair
Posted inMedical Technology

FDA approves Humacyte’s off-the-shelf artery implant for vascular trauma repair

December 23, 2024
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a…
Read More
ikena,-after-tough-year-of-layoffs,-merges-with-inmagene-to-focus-on-phase-2-dermatitis-prospect
Posted inBiotechnology

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect

December 23, 2024
After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found…
Read More
rapt-re-rolls-after-flameout,-paying-$35m-for-challenger-to-novartis,-roche-drug
Posted inBiotechnology

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug

December 23, 2024
Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a…
Read More
sanofi-pays-sk-bioscience-e50m-as-children’s-pneumococcal-vaccine-enters-phase-3
Posted inBiotechnology

Sanofi pays SK bioscience €50M as children’s pneumococcal vaccine enters phase 3

December 23, 2024
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine…
Read More
phase-2-data-will-drive-biopharma-vc-investments-next-year:-pitchbook
Posted inBiotechnology

Phase 2 data will drive biopharma VC investments next year: PitchBook

December 23, 2024
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into…
Read More
stockwatch:-wall-street’s-leaders-and-laggards-of-2024
Posted inGenetics

StockWatch: Wall Street’s Leaders and Laggards of 2024

December 21, 2024
2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging…
Read More
Posted inBiotechnology

Discover Astellas’ differentiated approach to innovation partnerships

December 20, 2024
As a global life sciences company, Astellas is passionate about partnering to advance life-changing treatments for patients. If you are…
Read More
clinical-trials-industry-to-grapple-with-new-tech,-additional-uncertainty-in-2025:-velocity-clinical-research-ceo
Posted inResearch

Clinical trials industry to grapple with new tech, additional uncertainty in 2025: Velocity Clinical Research CEO

December 20, 2024
Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and…
Read More
galectin’s-mash-treatment-reduces-varices-but-fails-to-hit-statistical-significance-in-phase-3-trial
Posted inBiotechnology

Galectin’s MASH treatment reduces varices but fails to hit statistical significance in phase 3 trial

December 20, 2024
Galectin Therapeutics’ stock has halved since the company revealed its investigational drug failed to significantly reduce enlarged veins for people…
Read More

Posts pagination

Previous page 1 … 1,360 1,361 1,362 1,363 1,364 … 1,376 Next page
You May Have Missed
quest-launches-residual-disease-blood-test-for-multiple-myeloma
Posted inMedical Technology

Quest launches residual disease blood test for multiple myeloma

optellum-tapped-by-nhs-for-ai-powered-lung-cancer-diagnostic-initiative
Posted inMedical Technology

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

a-month-after-alcon-deal-fell-through,-staar-surgical-searches-for-next-ceo-and-names-interim-leaders
Posted inMedical Technology

A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders

astrazeneca-study-finds-22-genes-tied-to-chronic-disease-risk-after-epstein-barr-infection
Posted inMedical Technology

AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection

Privacy Policy    Terms

Scroll to Top